{"corpus_id":5766958,"paper_sha":"ddc135a835da98f78dcfea7fd6dddd1fb238b7b9","doi":"10.1161/JAHA.116.004421","arxiv_id":null,"pmid":27742615,"pmcid":"5121526","mag_id":2530458202,"dblp_id":null,"acl_id":null,"title":"Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature","year":2016,"publication_date":"2016-10-01","venue":"Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease","journal":{"name":"Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease","pages":null,"volume":"5"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":55,"citation_count":73,"influential_citation_count":5,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adventitia","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D063194"},{"d":"Animals","mj":false,"ui":"D000818"},{"d":"Arteries","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D001158"},{"d":"Blood Pressure","mj":false,"qs":[{"q":"drug effects","mj":false,"ui":"Q000187"}],"ui":"D001794"},{"d":"Chemokines","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D018925"},{"d":"Chimerin Proteins","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"}],"ui":"D020740"},{"d":"Endothelium, Vascular","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D004730"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Immunohistochemistry","mj":false,"ui":"D007150"},{"d":"Intercellular Signaling Peptides and Proteins","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D036341"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Muscle, Smooth, Vascular","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D009131"},{"d":"Peptide Fragments","mj":false,"qs":[{"q":"pharmacology","mj":false,"ui":"Q000494"}],"ui":"D010446"},{"d":"Rats","mj":false,"ui":"D051381"},{"d":"Rats, Sprague-Dawley","mj":false,"ui":"D017207"},{"d":"Receptors, Chemokine","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D019707"},{"d":"Receptors, G-Protein-Coupled","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D043562"},{"d":"Saphenous Vein","mj":false,"qs":[{"q":"drug effects","mj":false,"ui":"Q000187"}],"ui":"D012501"},{"d":"Vasoconstriction","mj":false,"qs":[{"q":"drug effects","mj":false,"ui":"Q000187"}],"ui":"D014661"},{"d":"Veins","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D014680"}],"chemicals":[{"n":"CMKLR1 protein, human","ui":"C102741","reg":"0"},{"n":"Chemokines","ui":"D018925","reg":"0"},{"n":"Chimerin Proteins","ui":"D020740","reg":"0"},{"n":"Cmklr1 protein, rat","ui":"C109811","reg":"0"},{"n":"GPR1 protein, human","ui":"C504821","reg":"0"},{"n":"Intercellular Signaling Peptides and Proteins","ui":"D036341","reg":"0"},{"n":"Peptide Fragments","ui":"D010446","reg":"0"},{"n":"RARRES2 protein, human","ui":"C478630","reg":"0"},{"n":"Rarres2 protein, rat","ui":"C560738","reg":"0"},{"n":"Receptors, Chemokine","ui":"D019707","reg":"0"},{"n":"Receptors, G-Protein-Coupled","ui":"D043562","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/JAHA.116.004421","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/ddc135a835da98f78dcfea7fd6dddd1fb238b7b9","s2_open_access_license":"CCBYNCND","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Background Circulating levels of chemerin are significantly higher in hypertensive patients and positively correlate with blood pressure. Chemerin activates chemokine‐like receptor 1 (CMKLR1 or ChemR23) and is proposed to activate the “orphan” G‐protein‐coupled receptor 1 (GPR1), which has been linked with hypertension. Our aim was to localize chemerin, CMKLR1, and GPR1 in the human vasculature and determine whether 1 or both of these receptors mediate vasoconstriction. Methods and Results Using immunohistochemistry and molecular biology in conduit arteries and veins and resistance vessels, we localized chemerin to endothelium, smooth muscle, and adventitia and found that CMKLR1 and GPR1 were widely expressed in smooth muscle. C9 (chemerin149–157) contracted human saphenous vein (pD 2=7.30±0.31) and resistance arteries (pD 2=7.05±0.54) and increased blood pressure in rats by 9.1±1.0 mm Hg at 200 nmol. Crucially, these in vitro and in vivo vascular actions were blocked by CCX832, which we confirmed to be highly selective for CMKLR1 over GPR1. C9 inhibited cAMP accumulation in human aortic smooth muscle cells and preconstricted rat aorta, consistent with the observed vasoconstrictor action. Downstream signaling was explored further and, compared to chemerin, C9 showed a bias factor=≈5000 for the Gi protein pathway, suggesting that CMKLR1 exhibits biased agonism. Conclusions Our data suggest that chemerin acts at CMKLR1, but not GPR1, to increase blood pressure. Chemerin has an established detrimental role in metabolic syndrome, and these direct vascular actions may contribute to hypertension, an additional risk factor for cardiovascular disease. This study provides proof of principle for the therapeutic potential of selective CMKLR1 antagonists.","claims":[{"public_id":"cl_cde60f5f29cdbceb4010159f0833fc8b","status":"active","text":"C9 inhibits cAMP accumulation and shows strong Gi pathway bias relative to chemerin, consistent with biased agonism at CMKLR1.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_cde60f5f29cdbceb4010159f0833fc8b"},{"public_id":"cl_7079c46dd1f326e0d88397294994ffbe","status":"active","text":"Chemerin acts at CMKLR1, but not GPR1, to increase blood pressure, suggesting selective CMKLR1 antagonists have therapeutic potential.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_7079c46dd1f326e0d88397294994ffbe"},{"public_id":"cl_6817cc3d214917c763644c2da42dcc75","status":"active","text":"Chemerin localizes to the endothelium, smooth muscle, and adventitia in human vasculature, while CMKLR1 and GPR1 are widely expressed in smooth muscle.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_6817cc3d214917c763644c2da42dcc75"},{"public_id":"cl_8aac4f6c80a49f5b232c6a725dc02cc3","status":"active","text":"The chemerin fragment C9 constricts human saphenous vein and resistance arteries and increases blood pressure in rats.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_8aac4f6c80a49f5b232c6a725dc02cc3"},{"public_id":"cl_3e444cb4bcda888e5bd30394a419083d","status":"active","text":"The vascular and blood pressure effects of C9 are blocked by CCX832, supporting CMKLR1-mediated vasoconstriction.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_3e444cb4bcda888e5bd30394a419083d"}],"concepts":[{"public_id":"co_4db2d2687872ca369f612642175f850a","status":"active","name":"selective CMKLR1 antagonists","description":"Compounds designed to block CMKLR1 more selectively than related receptors.","types":["therapeutic candidate"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_4db2d2687872ca369f612642175f850a"},{"public_id":"co_5cc75e9298b7a55639fbe342d423f0d1","status":"active","name":"GPR1","description":"An orphan G-protein-coupled receptor investigated here as a potential chemerin receptor.","types":["receptor"],"aliases":["G-protein-coupled receptor 1"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5cc75e9298b7a55639fbe342d423f0d1"},{"public_id":"co_68456dcb4cdb3dcb43ec3f223ffc3646","status":"active","name":"cAMP accumulation","description":"Cellular cyclic AMP production measured as a signaling readout downstream of receptor activation.","types":["signaling readout"],"aliases":["cyclic AMP accumulation"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_68456dcb4cdb3dcb43ec3f223ffc3646"},{"public_id":"co_7f004624765335bc0937f0649ead9ba5","status":"active","name":"resistance arteries","description":"Small-caliber arteries that contribute strongly to peripheral vascular resistance and were tested for constriction.","types":["vessel"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7f004624765335bc0937f0649ead9ba5"},{"public_id":"co_8025fc313708ede085179d34b733dd54","status":"active","name":"CCX832","description":"A pharmacological antagonist used to test receptor specificity for CMKLR1 versus GPR1.","types":["antagonist"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8025fc313708ede085179d34b733dd54"},{"public_id":"co_81f848e890b9a8c96e0d01a32c5c8c38","status":"active","name":"vasoconstriction","description":"Constriction of blood vessels that reduces vessel diameter and can raise blood pressure.","types":["physiological response"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_81f848e890b9a8c96e0d01a32c5c8c38"},{"public_id":"co_8d957be222ff0481721454c3d25a4d37","status":"active","name":"chemerin","description":"A circulating adipokine/chemokine-like ligand investigated for its vascular effects.","types":["ligand"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8d957be222ff0481721454c3d25a4d37"},{"public_id":"co_8f38aab55b9fd984b40104baea32b990","status":"active","name":"biased agonism","description":"Preferential activation of one downstream signaling pathway over others by a ligand at a receptor.","types":["pharmacological property"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_8f38aab55b9fd984b40104baea32b990"},{"public_id":"co_b478a14eb1ade2c1137d05b95d6b8c20","status":"active","name":"human vasculature","description":"The blood vessels of humans used for localization and functional testing.","types":["biological system"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b478a14eb1ade2c1137d05b95d6b8c20"},{"public_id":"co_b7ffedd60827dbc77caab227212609ee","status":"active","name":"human saphenous vein","description":"A human vein used as an ex vivo vascular preparation to test contractile responses.","types":["tissue"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b7ffedd60827dbc77caab227212609ee"},{"public_id":"co_c4ebda7a587415bad61bf62cb4f18a5f","status":"active","name":"Gi protein pathway","description":"A G-protein signaling route associated with inhibitory receptor signaling in the reported assays.","types":["signaling pathway"],"aliases":["Gi pathway"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c4ebda7a587415bad61bf62cb4f18a5f"},{"public_id":"co_d0676e2b74eeb1208187d8936d4a821f","status":"active","name":"CMKLR1","description":"Chemokine-like receptor 1, a receptor that binds chemerin and is examined as a mediator of vascular responses.","types":["receptor"],"aliases":["ChemR23"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_d0676e2b74eeb1208187d8936d4a821f"},{"public_id":"co_f8f1f709c1bcca76981c95f979cf55b3","status":"active","name":"C9","description":"Chemerin149–157, a peptide fragment used as the active vascular agonist in the experiments.","types":["peptide"],"aliases":["chemerin149–157"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f8f1f709c1bcca76981c95f979cf55b3"}],"external_ids":{"DOI":"10.1161/JAHA.116.004421","ArXiv":null,"PubMed":27742615,"PubMedCentral":"5121526","MAG":2530458202,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/JAHA.116.004421","landing_url":"https://www.semanticscholar.org/paper/ddc135a835da98f78dcfea7fd6dddd1fb238b7b9","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNCND","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":635333,"paper_uid":"11a73a58-5eed-4894-b77b-7c9dd62aec5d","canonical_identity":{"paper_id":635333,"paper_uid":"11a73a58-5eed-4894-b77b-7c9dd62aec5d","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/5766958"}